Weak interactionIn nuclear physics and particle physics, the weak interaction, which is also often called the weak force or weak nuclear force, is one of the four known fundamental interactions, with the others being electromagnetism, the strong interaction, and gravitation. It is the mechanism of interaction between subatomic particles that is responsible for the radioactive decay of atoms: The weak interaction participates in nuclear fission and nuclear fusion.
Electroweak interactionIn particle physics, the electroweak interaction or electroweak force is the unified description of two of the four known fundamental interactions of nature: electromagnetism (electromagnetic interaction) and the weak interaction. Although these two forces appear very different at everyday low energies, the theory models them as two different aspects of the same force. Above the unification energy, on the order of 246 GeV, they would merge into a single force.
Weak isospinIn particle physics, weak isospin is a quantum number relating to the electrically charged part of the weak interaction: Particles with half-integer weak isospin can interact with the _W boson+- bosons; particles with zero weak isospin do not. Weak isospin is a construct parallel to the idea of isospin under the strong interaction. Weak isospin is usually given the symbol T or I, with the third component written as T_3 or I_3. It can be understood as the eigenvalue of a charge operator.
Strong interactionIn nuclear physics and particle physics, the strong interaction, which is also often called the strong force or strong nuclear force, is a fundamental interaction that confines quarks into proton, neutron, and other hadron particles. The strong interaction also binds neutrons and protons to create atomic nuclei, where it is called the nuclear force. Most of the mass of a common proton or neutron is the result of the strong interaction energy; the individual quarks provide only about 1% of the mass of a proton.
ProteinProteins are large biomolecules and macromolecules that comprise one or more long chains of amino acid residues. Proteins perform a vast array of functions within organisms, including catalysing metabolic reactions, DNA replication, responding to stimuli, providing structure to cells and organisms, and transporting molecules from one location to another. Proteins differ from one another primarily in their sequence of amino acids, which is dictated by the nucleotide sequence of their genes, and which usually results in protein folding into a specific 3D structure that determines its activity.
Fundamental interactionIn physics, the fundamental interactions or fundamental forces are the interactions that do not appear to be reducible to more basic interactions. There are four fundamental interactions known to exist: gravity electromagnetism weak interaction strong interaction The gravitational and electromagnetic interactions produce long-range forces whose effects can be seen directly in everyday life. The strong and weak interactions produce forces at minuscule, subatomic distances and govern nuclear interactions inside atoms.
Neutral currentWeak neutral current interactions are one of the ways in which subatomic particles can interact by means of the weak force. These interactions are mediated by the Z boson. The discovery of weak neutral currents was a significant step toward the unification of electromagnetism and the weak force into the electroweak force, and led to the discovery of the W and Z bosons. The weak force is best known for its role in nuclear decay. It has very short range but (apart from gravity) is the only force to interact with neutrinos.
Synaptic vesicleIn a neuron, synaptic vesicles (or neurotransmitter vesicles) store various neurotransmitters that are released at the synapse. The release is regulated by a voltage-dependent calcium channel. Vesicles are essential for propagating nerve impulses between neurons and are constantly recreated by the cell. The area in the axon that holds groups of vesicles is an axon terminal or "terminal bouton". Up to 130 vesicles can be released per bouton over a ten-minute period of stimulation at 0.2 Hz.
Weak hyperchargeIn the Standard Model of electroweak interactions of particle physics, the weak hypercharge is a quantum number relating the electric charge and the third component of weak isospin. It is frequently denoted and corresponds to the gauge symmetry U(1). It is conserved (only terms that are overall weak-hypercharge neutral are allowed in the Lagrangian). However, one of the interactions is with the Higgs field. Since the Higgs field vacuum expectation value is nonzero, particles interact with this field all the time even in vacuum.
Protein–protein interactionProtein–protein interactions (PPIs) are physical contacts of high specificity established between two or more protein molecules as a result of biochemical events steered by interactions that include electrostatic forces, hydrogen bonding and the hydrophobic effect. Many are physical contacts with molecular associations between chains that occur in a cell or in a living organism in a specific biomolecular context. Proteins rarely act alone as their functions tend to be regulated.
Weak chargeIn nuclear physics and atomic physics, weak charge refers to the Standard Model weak interaction coupling of a particle to the Z boson. For example, for any given nuclear isotope, the total weak charge is approximately −0.99 per neutron, and +0.07 per proton. It also shows an effect of parity violation during electron scattering. This same term is sometimes also used to refer to other, distinct quantities, such as weak isospin, weak hypercharge, or the vector coupling of a fermion to the Z boson (i.e.
Receptor antagonistA receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist. Antagonist drugs interfere in the natural operation of receptor proteins. They are sometimes called blockers; examples include alpha blockers, beta blockers, and calcium channel blockers. In pharmacology, antagonists have affinity but no efficacy for their cognate receptors, and binding will disrupt the interaction and inhibit the function of an agonist or inverse agonist at receptors.
C-symmetryIn physics, charge conjugation is a transformation that switches all particles with their corresponding antiparticles, thus changing the sign of all charges: not only electric charge but also the charges relevant to other forces. The term C-symmetry is an abbreviation of the phrase "charge conjugation symmetry", and is used in discussions of the symmetry of physical laws under charge-conjugation. Other important discrete symmetries are P-symmetry (parity) and T-symmetry (time reversal).
High-throughput screeningHigh-throughput screening (HTS) is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology, materials science and chemistry. Using robotics, data processing/control software, liquid handling devices, and sensitive detectors, high-throughput screening allows a researcher to quickly conduct millions of chemical, genetic, or pharmacological tests. Through this process one can quickly recognize active compounds, antibodies, or genes that modulate a particular biomolecular pathway.
CP violationIn particle physics, CP violation is a violation of CP-symmetry (or charge conjugation parity symmetry): the combination of C-symmetry (charge symmetry) and P-symmetry (parity symmetry). CP-symmetry states that the laws of physics should be the same if a particle is interchanged with its antiparticle (C-symmetry) while its spatial coordinates are inverted ("mirror" or P-symmetry). The discovery of CP violation in 1964 in the decays of neutral kaons resulted in the Nobel Prize in Physics in 1980 for its discoverers James Cronin and Val Fitch.
Ligand binding assayA ligand binding assay (LBA) is an assay, or an analytic procedure, which relies on the binding of ligand molecules to receptors, antibodies or other macromolecules. A detection method is used to determine the presence and extent of the ligand-receptor complexes formed, and this is usually determined electrochemically or through a fluorescence detection method. This type of analytic test can be used to test for the presence of target molecules in a sample that are known to bind to the receptor.
Protein foldingProtein folding is the physical process where a protein chain is translated into its native three-dimensional structure, typically a "folded" conformation, by which the protein becomes biologically functional. Via an expeditious and reproducible process, a polypeptide folds into its characteristic three-dimensional structure from a random coil. Each protein exists first as an unfolded polypeptide or random coil after being translated from a sequence of mRNA into a linear chain of amino acids.
White blood cellWhite blood cells, also called leukocytes or leucocytes, are cells of the immune system that are involved in protecting the body against both infectious disease and foreign invaders. White blood cells include three main subtypes; granulocytes, lymphocytes and monocytes. White cells is most preferred rather than the, white blood cells, because, they spend most of their time in the lymph or plasma. All white blood cells are produced and derived from multipotent cells in the bone marrow known as hematopoietic stem cells.
Membrane proteinMembrane proteins are common proteins that are part of, or interact with, biological membranes. Membrane proteins fall into several broad categories depending on their location. Integral membrane proteins are a permanent part of a cell membrane and can either penetrate the membrane (transmembrane) or associate with one or the other side of a membrane (integral monotopic). Peripheral membrane proteins are transiently associated with the cell membrane.
Hematopoietic stem cellHematopoietic stem cells (HSCs) are the stem cells that give rise to other blood cells. This process is called haematopoiesis. In vertebrates, the very first definitive HSCs arise from the ventral endothelial wall of the embryonic aorta within the (midgestational) aorta-gonad-mesonephros region, through a process known as endothelial-to-hematopoietic transition. In adults, haematopoiesis occurs in the red bone marrow, in the core of most bones. The red bone marrow is derived from the layer of the embryo called the mesoderm.
